neoplas med is a spin-off of the Leibniz Institute (INP) for Plasma Research and Technology in Greifswald and an innovative pioneering, emerging company in the field of medical technology.
Our goal is to advance the fascinating possibilities of plasma medicine – and thus improve the quality of life of people with acute and chronic wounds.
The first milestone is the precision technology, the cold plasma jet kINPen® MED – a leap innovation and disruptive technology that will revolutionize the wound care market, manufactured in Germany. We are proud to have the worlds’ best evidence-based technology, scientifically studied like no other cold plasma device.
Our journey started in DACH where we reached the “proof of concept”. With our new strategic partner, the Tech Group NITERRA (previous NGK Spark Plugs), we are now planning to conquer the international markets to make our therapy available to all patients.
As an emerging company with an international focus, the culture is characterized by agility, flat hierarchies, results-oriented “can-do” mentality and team spirit. A high degree of empowerment offers the opportunity to
bring your own ideas into the company and implement them.
